APA (7th ed.) Citation

SSA, E., AI, M., ARN, I., & M, E. (2026). Mechanistic insights into the anti-benign prostatic hyperplasia effect of dihydromyricetin via suppression of the 5-AR/TGF-β1/Smad2 axis. Naunyn-Schmiedeberg's archives of pharmacology, 399(7), 10323. https://doi.org/10.1007/s00210-026-04998-3

Chicago Style (17th ed.) Citation

SSA, El-Hameed, Matouk AI, Ibrahim ARN, and El-Daly M. "Mechanistic Insights into the Anti-benign Prostatic Hyperplasia Effect of Dihydromyricetin via Suppression of the 5-AR/TGF-β1/Smad2 Axis." Naunyn-Schmiedeberg's Archives of Pharmacology 399, no. 7 (2026): 10323. https://doi.org/10.1007/s00210-026-04998-3.

MLA (9th ed.) Citation

SSA, El-Hameed, et al. "Mechanistic Insights into the Anti-benign Prostatic Hyperplasia Effect of Dihydromyricetin via Suppression of the 5-AR/TGF-β1/Smad2 Axis." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 399, no. 7, 2026, p. 10323, https://doi.org/10.1007/s00210-026-04998-3.